Navigation Links
AIDS Vaccines: Where Do We Go From Here?
Date:7/28/2008

The International AIDS Vaccine Initiative (IAVI) and Key Thought Leaders Explore Critical Next Steps for AIDS Vaccine Research at the 17th International AIDS Conference in Mexico City

NEW YORK, July 28 /PRNewswire-USNewswire/ -- The following was released today by the International AIDS Vaccine Initiative:

WHAT:

Today, AIDS vaccine research is at a pivotal moment. Just ten months ago, the second AIDS vaccine candidate to reach late-stage testing failed. In the wake of this disappointment, some skeptics have argued that an AIDS vaccine may not be possible and that resources dedicated to its development should be directed instead towards treating HIV-infected individuals. Now is the time to take a hard look at the toughest questions currently facing AIDS vaccine researchers. How should the finite resources for AIDS vaccine research be prioritized? How can the toughest scientific questions facing AIDS vaccine researchers be tackled? What criteria should be used to decide which vaccine candidates merit further testing, and which should be dropped? How do you continue to sustain much-needed support for a preventive vaccine that may take decades to develop?

In its biennial AIDS Vaccine Blueprint: A Challenge to the Field, a Roadmap for Progress, IAVI will put forth a series of concrete recommendations and milestones that will guide research to answer the critical scientific questions that have hampered AIDS vaccine development to date.

WHY:

The AIDS pandemic is one of the greatest global health crises of our time. In the 25 years since HIV was first identified as the cause of AIDS, an estimated 25 million people have died of the disease and 33 million more are currently living with HIV. Almost 7,000 people become newly infected with HIV everyday, and for every two people who start antiretroviral therapy, another five become newly infected with HIV. While a preventive vaccine is the best long-term solution to the pandemic, much still remains to be done to discover and make a vaccine accessible globally.

WHO:

Seth Berkley, MD, CEO and President, International AIDS Vaccine Initiative (IAVI)

Peter Piot, MD, Executive Director, UNAIDS and Under Secretary-General, United Nations

Alan Bernstein, MD, Executive Director, Global HIV Vaccine Enterprise

Omu Anzala, MD, Associate Professor, University of Nairobi School of Medicine

WHERE:

Media Centre, Room 2

WHEN:

Tuesday, August 5 (9:00AM to 9:45AM)

CONTACT: Hester Kuipers

hkuipers@iavi.org

+31 20 5210343 / +31 64898130

Rachel Steinhardt

rsteinhardt@iavi.org

212-847-1045


'/>"/>
SOURCE International AIDS Vaccine Initiative
Copyright©2008 PR Newswire.
All rights reserved

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016 The Academy of ... recommendations that would allow biopharmaceutical companies to ... entities that make formulary and coverage decisions, a move ... of new medicines. The recommendations address restrictions ... appear on the drug label, a prohibition that hinders ...
(Date:6/24/2016)... PUNE, India , June 24, 2016 ... "Pen Needles Market by Type (Standard Pen Needles, Safety ... 12mm), Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase ... published by MarketsandMarkets, This report studies the market for ... is expected to reach USD 2.81 Billion by 2021 ...
(Date:6/23/2016)... -- MedSource announced today that it has selected Datatrial,s ... choice.  This latest decision demonstrates MedSource,s commitment to ... by offering a state-of-the-art electronic data capture (EDC) ... the EDC platform of choice in exchange for ... long been a preferred EDC platform by our ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the ... Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , “We ... new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a method ... —Johnson is one of the first doctors to perform the treatment. Orthobiologics are ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, whether ... latter, setting the bar too high can result in disappointment, perhaps even self-loathing. However, ... their goal. , Research from PsychTests.com reveals that behind the tendency ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic ... many turn to unhealthy avenues, such as drug or alcohol abuse, as a coping ... released tools for healthy coping following a traumatic event. , Trauma sufferers tend to ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Marcy was in a crisis. Her son James, ... out at his family verbally and physically. , “When something upset him, he couldn’t control ... use it. He would throw rocks at my other children and say he was going ...
Breaking Medicine News(10 mins):